BrainsWay Ltd.
BWAY · NASDAQ
Bulios Fair Price
$17.31
47.1% upside
Current Price
$11.77
According to Bulios Fair Price, BWAY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
BrainsWay Ltd. (BWAY) is a global company specializing in the development and production of non-invasive neurostimulation devices for the treatment of various neurological and psychiatric disorders. With innovative technologies and treatment approaches, including transcranial magnetic stimulation (TMS), BrainsWay Ltd. is a key player in the field of neuromodulation. The company focuses on providing effective and safe therapeutic options for patients with neurological and psychiatric disorders. BrainsWay Ltd. (BWAY) shares could be suitable for investors looking to invest in the innovative healthcare sector focused on neurological treatments.
Sector
Healthcare
Industry
Medical - Specialties
CEO
Hadar Levy
Employees
129
Headquarters
Jerusalem
Upcoming events
Earnings
Upcoming earnings report